Streptococcus pneumoniae causes several diseases, including pneumonia, septicemia, and meningitis. Phage Dp-1 is one of the very few isolated virulent S. pneumoniae bacteriophages, but only a partial characterization is currently available. Here, we confirmed that Dp-1 belongs to the family Siphoviridae. Then, we determined its complete genomic sequence of 56,506 bp. It encodes 72 open reading frames, of which 44 have been assigned a function. We have identified putative promoters, Rho-independent terminators, and several genomic clusters. We provide evidence that Dp-1 may be using a novel DNA replication system as well as redirecting host protein synthesis through queuosine-containing tRNAs. Liquid chromatography-mass spectrometry analysis of purified phage Dp-1 particles identified at least eight structural proteins. Finally, using comprehensive yeast two-hybrid screens, we identified 156 phage protein interactions, and this intraviral interactome was used to propose a structural model of Dp-1.Streptococcus pneumoniae (pneumococcus) is a low-GC-content, Gram-positive bacterium belonging to the mitis group of streptococci (40). It is a facultative human pathogen, colonizing the mucosal surface of the upper respiratory tract and causing invasive infections such as pneumonia, meningitis, and sepsis (97). S. pneumoniae diseases are associated with severe morbidity and a high rate of mortality, especially among young children and the elderly. Antibiotics are commonly used to control and cure the invasive pneumococcal diseases, but this high exposure to antibiotics has led to multiresistant S. pneumoniae strains worldwide (79). Vaccination is efficient in preventing invasive diseases (103), but pneumococcal clones expressing capsular polysaccharides with serotypes not included in the current vaccines' formulations exist, and the incidence of invasive diseases induced by these vaccine-escaping clones is increasing (34). Replacement of the vaccine-included clones by the vaccine-escaping ones is possible (91).The appearance of antibiotic-resistant and vaccine-escaping clones is partly due to the high genome plasticity of S. pneumoniae. This genome plasticity is supported by the ability of the pneumococcus to acquire DNA through natural competence and by genome rearrangements facilitated by the mobile elements present in its genome (15,43,93). S. pneumoniae is also able to colonize many sites inside the human host using phase variation of cell surface components such as polysaccharide capsule, lipoteichoic acid, and cell-surface expressed proteins (42,78,101). The complexity of physiology and genetics of S. pneumoniae complicates the search for novel therapeutic approaches needed to counter increasing antibiotic resistance and emergence of the vaccine-escaping clones.One of the novel therapeutic approaches toward antibioticresistant strains is the use of bacteriophage proteins to lyse pneumococcus cells. The feasibility of this approach was first demonstrated when bacteriophage endolysin enzymes were used successfully t...